Thoracic Research and Practice
Original Article

Coronavirus Disease 2019 Frequency After CoronaVac Vaccine: Ascovid Study


Department of Pulmonary Medicine, Gazi University, Faculty of Medicine, Ankara, Turkey


Department of Pulmonary Medicine, Delta Hospital, İstanbul, Turkey


Department of Pulmonary Medicine, Çukurova University, Faculty of Medicine, Adana, Turkey


Department of Nuclear Medicine, Integra Medical Imaging Center, Ankara, Turkey

Thorac Res Pract 2023; 24: 29-33
DOI: 10.5152/ThoracResPract.2022.22045
Read: 42 Downloads: 26 Published: 01 January 2023

OBJECTIVE: It is accepted that the only way to end severe acute respiratory syndrome coronavirus 2 epidemic is through community vaccination. The frequency and clinical features of infection after vaccination are not known clearly. The aim of this study is to determine the frequency and clinical features of coronavirus disease 2019 seen after either the first or second dose of CoronaVac vaccination in healthcare workers and their relatives.

MATERIAL AND METHODS: This is a cross-sectional retrospective survey study. The study was carried out in 2013 volunteers, including 1903 (94.5%) healthcare workers and 110 (5.5%) relatives of healthcare workers. The frequency and clinical features of coronavirus disease 2019 before and after the first or second dose of CoronaVac vaccination were retrospectively evaluated using an online questionnaire conducted in July 2021.

RESULTS: A total of 2013 people, 1312 women and 701 men, participated in the study. Of these individuals, 245 (12.1%) were polymerase chain reaction positive for coronavirus disease 2019 before vaccination. Of this group, 185 (75.5% of polymerase chain reaction positives and 9.1% of the whole population) received home-based therapy, while 38 (15.5%) received hospital admission. Asymptomatic polymerase chain reaction positivity before vaccination was seen in 22 (9%) individuals. There were 177 (8.8%) participants who developed polymerase chain reaction positivity at any time after vaccination. In 129 (72.8%) of these participants, polymerase chain reaction positivity occurred 21 days after the second dose of vaccine. While the number of patients hospitalized before vaccination was 38 (15.5% of the polymerase chain reaction positivity group and 1.89% of the general population), the number of patients hospitalized after the vaccination was 17 (10.1% of the polymerase chain reaction positivity group and 0.80% of the general population). The decrease in hospitalization proportion was statistically significant (P = .002).

CONCLUSION: The frequency of coronavirus disease 2019, severe illness, and hospitalization rates were found to be lower in postvaccination period. The vaccine is effective in preventing coronavirus disease 2019 and severe disease.

Cite this article as: Öztürk Şahin B, Özen Ş, Baydar Toprak O, Köktürk N, Tevfik Kitapçı M. Coronavirus disease 2019 frequency after CoronaVac vaccine: Ascovid study. Thorac Res Pract. 2023;24(1):29-33.

EISSN 2979-9139